(Times of Israel) Israel's Micromedic Technologies says its initial test of its Celldetect technology detected or ruled out prostate cancer in urine samples more accurately than the current PSA blood test. Tests of CellDetect have previously proven similarly high efficacy rates for detecting cervical and bladder cancer.
2018-03-02 00:00:00Full ArticleBACK Visit the Daily Alert Archive